Published in J Clin Oncol on June 20, 2011
Methods in comparative effectiveness research. J Clin Oncol (2012) 1.12
Using group-based trajectory modeling to examine heterogeneity of symptom burden in patients with head and neck cancer undergoing aggressive non-surgical therapy. Qual Life Res (2013) 1.04
Family caregiver burden, skills preparedness, and quality of life in non-small cell lung cancer. Oncol Nurs Forum (2013) 0.99
Interdisciplinary palliative care intervention in metastatic non-small-cell lung cancer. Clin Lung Cancer (2013) 0.89
Changes in pain and other symptoms in patients with painful multiple myeloma-related vertebral fracture treated with kyphoplasty or vertebroplasty. J Pain (2012) 0.85
Screening for depressed mood in patients with cancer using the MD Anderson Symptom Inventory: investigation of a practical approach for the oncologist. J Oncol Pract (2013) 0.85
Prescription coverage in indigent patients affects the use of long-acting opioids in the management of cancer pain. Pain Med (2013) 0.78
Socioeconomic status is associated with depressive severity among patients with advanced non-small-cell lung cancer: treatment setting and minority status do not make a difference. J Thorac Oncol (2014) 0.77
Prognostic value of patient-reported symptom interference in patients with late-stage lung cancer. Qual Life Res (2013) 0.76
Integrating social work into palliative care for lung cancer patients and families: a multidimensional approach. J Psychosoc Oncol (2014) 0.75
Predictors of the multidimensional symptom experience of lung cancer patients receiving chemotherapy. Support Care Cancer (2017) 0.75
Symptom profiles in children with advanced cancer: Patient, family caregiver, and oncologist ratings. Cancer (2015) 0.75
Quantitative tool to evaluate the somatic burden due to chemotherapy-induced adverse events: the somatic burden score. Support Care Cancer (2014) 0.75
Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol (1982) 43.81
Validation of a combined comorbidity index. J Clin Epidemiol (1994) 19.43
Pain and its treatment in outpatients with metastatic cancer. N Engl J Med (1994) 9.54
"We don't carry that"--failure of pharmacies in predominantly nonwhite neighborhoods to stock opioid analgesics. N Engl J Med (2000) 7.56
Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer (2000) 7.25
Management of pain in elderly patients with cancer. SAGE Study Group. Systematic Assessment of Geriatric Drug Use via Epidemiology. JAMA (1998) 6.88
When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain (1995) 5.97
National Institutes of Health State-of-the-Science Conference Statement: Symptom Management in Cancer: Pain, Depression, and Fatigue, July 15-17, 2002. J Natl Cancer Inst (2003) 2.99
Symptom burden: multiple symptoms and their impact as patient-reported outcomes. J Natl Cancer Inst Monogr (2007) 2.63
Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory. Oncologist (2011) 1.30
Addition of bevacizumab to chemotherapy for treatment of solid tumors: similar results but different conclusions. J Clin Oncol (2010) 1.22
Perceptions of health care provider communication activity among American cancer survivors and Adults Without Cancer Histories: an analysis of the 2003 Health Information Trends Survey (HINTS) Data. J Health Commun (2008) 1.07
Exploring the financial impact of breast cancer for African American medically underserved women: a qualitative study. J Health Care Poor Underserved (2009) 1.05
Prognostic value of symptom burden for overall survival in patients receiving chemotherapy for advanced nonsmall cell lung cancer. Cancer (2010) 1.03
Race in ovarian cancer treatment and survival: a systematic review with meta-analysis. Cancer Causes Control (2009) 1.03
Impact of cultural and linguistic factors on symptom reporting by patients with cancer. J Natl Cancer Inst (2010) 1.03
Cancer epidemiology in the United States: racial, social, and economic factors. Methods Mol Biol (2009) 1.03
Does an oral analgesic protocol improve pain control for patients with cancer? An intergroup study coordinated by the Eastern Cooperative Oncology Group. Ann Oncol (2005) 0.98
Impact of androgen deprivation therapy on racial/ethnic disparities in the survival of older men treated for locoregional prostate cancer. Cancer Control (2009) 0.89
Advanced stage of head and neck cancer at a tertiary-care county hospital. Laryngoscope (2006) 0.87
Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med (2010) 22.74
Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med (2013) 19.87
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature (2012) 14.33
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature (2012) 9.89
The origin and evolution of mutations in acute myeloid leukemia. Cell (2012) 9.66
Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus. Nature (2005) 8.55
Whole-genome analysis informs breast cancer response to aromatase inhibition. Nature (2012) 8.03
Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet (2012) 7.61
Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N Engl J Med (2014) 5.37
A novel retinoblastoma therapy from genomic and epigenetic analyses. Nature (2012) 5.02
Novel mutations target distinct subgroups of medulloblastoma. Nature (2012) 4.82
Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain. Clin J Pain (2004) 4.72
A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. JAMA (2011) 4.63
Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts. Cell Rep (2013) 3.85
Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer. J Clin Oncol (2012) 3.65
Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas. Nat Genet (2013) 3.51
The genomic landscape of hypodiploid acute lymphoblastic leukemia. Nat Genet (2013) 3.43
Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy. J Clin Oncol (2009) 2.75
Genome sequence of Theileria parva, a bovine pathogen that transforms lymphocytes. Science (2005) 2.71
Automated symptom alerts reduce postoperative symptom severity after cancer surgery: a randomized controlled clinical trial. J Clin Oncol (2011) 2.70
Association of age at diagnosis and genetic mutations in patients with neuroblastoma. JAMA (2012) 2.49
Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer (2003) 2.48
Use of radiation therapy in the last 30 days of life among a large population-based cohort of elderly patients in the United States. J Clin Oncol (2012) 2.38
Symptoms and quality of life in diverse patients undergoing hematopoietic stem cell transplantation. J Pain Symptom Manage (2012) 1.97
A cytokine-based neuroimmunologic mechanism of cancer-related symptoms. Neuroimmunomodulation (2004) 1.87
The Princeton Protein Orthology Database (P-POD): a comparative genomics analysis tool for biologists. PLoS One (2007) 1.83
Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy. Cytokine (2004) 1.70
Authors' reply to Tendas et al. J Pain Symptom Manage (2013) 1.66
Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancer. Cancer (2011) 1.63
Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module. Head Neck (2007) 1.63
Net clinical benefit analysis of radiation therapy oncology group 0525: a phase III trial comparing conventional adjuvant temozolomide with dose-intensive temozolomide in patients with newly diagnosed glioblastoma. J Clin Oncol (2013) 1.62
Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy. Brain Behav Immun (2010) 1.58
The Norwegian brief pain inventory questionnaire: translation and validation in cancer pain patients. J Pain Symptom Manage (2002) 1.58
Phase II trial of the histone deacetylase inhibitor vorinostat (Zolinza, suberoylanilide hydroxamic acid, SAHA) in patients with recurrent and/or metastatic head and neck cancer. Invest New Drugs (2007) 1.53
Longitudinal study of the relationship between chemoradiation therapy for non-small-cell lung cancer and patient symptoms. J Clin Oncol (2006) 1.52
Genetic variations in the regulator of G-protein signaling genes are associated with survival in late-stage non-small cell lung cancer. PLoS One (2011) 1.51
Predicting cellular growth from gene expression signatures. PLoS Comput Biol (2009) 1.50
Asking the community about cutpoints used to describe mild, moderate, and severe pain. J Pain (2006) 1.48
Fatigue and sleep disturbance in patients with cancer, patients with clinical depression, and community-dwelling adults. J Pain Symptom Manage (2003) 1.47
Cancer pain management among underserved minority outpatients: perceived needs and barriers to optimal control. Cancer (2002) 1.46
Serum interleukin-6 predicts the development of multiple symptoms at nadir of allogeneic hematopoietic stem cell transplantation. Cancer (2008) 1.43
Japanese version of the MD Anderson Symptom Inventory: a validation study. J Pain Symptom Manage (2003) 1.42
The Brief Pain Inventory and its "pain at its worst in the last 24 hours" item: clinical trial endpoint considerations. Pain Med (2010) 1.40
A randomized, double-blind, 2-period, placebo-controlled crossover trial of a sustained-release methylphenidate in the treatment of fatigue in cancer patients. Cancer J (2014) 1.40
Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma. J Clin Oncol (2012) 1.37
Long-term clinical outcome of intensity-modulated radiotherapy for inoperable non-small cell lung cancer: the MD Anderson experience. Int J Radiat Oncol Biol Phys (2011) 1.37
Chinese version of the M. D. Anderson Symptom Inventory: validation and application of symptom measurement in cancer patients. Cancer (2004) 1.32
Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy. Brain Behav Immun (2012) 1.31
Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory. Oncologist (2011) 1.30
Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy. J Natl Cancer Inst (2011) 1.27
Safety of early discharge for low-risk patients with febrile neutropenia: a multicenter randomized controlled trial. J Clin Oncol (2011) 1.26
Pain, depression, and fatigue in community-dwelling adults with and without a history of cancer. J Pain Symptom Manage (2006) 1.25
Development of a cancer pain assessment tool in Korea: a validation study of a Korean version of the brief pain inventory. Oncology (2004) 1.25
Cognitive interviewing of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Qual Life Res (2013) 1.21
Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians. Mutat Res (2004) 1.20
Validation study of the korean version of the brief fatigue inventory. J Pain Symptom Manage (2005) 1.18
Prevalence and characteristics of moderate to severe fatigue: a multicenter study in cancer patients and survivors. Cancer (2014) 1.17
MSIsensor: microsatellite instability detection using paired tumor-normal sequence data. Bioinformatics (2013) 1.17
Opposing effects of emphysema, hay fever, and select genetic variants on lung cancer risk. Am J Epidemiol (2005) 1.17
Pain education for underserved minority cancer patients: a randomized controlled trial. J Clin Oncol (2004) 1.15
Measuring the symptom burden associated with the treatment of chronic myeloid leukemia. Blood (2013) 1.14
Outcomes and cost of outpatient or inpatient management of 712 patients with febrile neutropenia. J Clin Oncol (2008) 1.14
Management of spinal metastases from renal cell carcinoma using stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys (2009) 1.13
Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer. PLoS One (2010) 1.12
Early findings on toxicity of proton beam therapy with concurrent chemotherapy for nonsmall cell lung cancer. Cancer (2011) 1.12
Validation study of the Korean version of the M. D. Anderson Symptom Inventory. J Pain Symptom Manage (2006) 1.12
Caregiver symptom burden: the risk of caring for an underserved patient with advanced cancer. Cancer (2010) 1.11
Clinical factors associated with cancer-related fatigue in patients being treated for leukemia and non-Hodgkin's lymphoma. J Clin Oncol (2002) 1.11
Analysis of the transcriptome of the protozoan Theileria parva using MPSS reveals that the majority of genes are transcriptionally active in the schizont stage. Nucleic Acids Res (2005) 1.09
Clinicians' practice and attitudes toward cancer pain management in Korea. Support Care Cancer (2006) 1.07
Cancer-related symptom assessment in Russia: validation and utility of the Russian M. D. Anderson Symptom Inventory. J Pain Symptom Manage (2005) 1.07
Stakeholder perspectives on implementing the National Cancer Institute's patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Transl Behav Med (2011) 1.07
Randomized safety and efficacy study of fosbretabulin with paclitaxel/carboplatin against anaplastic thyroid carcinoma. Thyroid (2013) 1.07
The M. D. Anderson symptom inventory-head and neck module, a patient-reported outcome instrument, accurately predicts the severity of radiation-induced mucositis. Int J Radiat Oncol Biol Phys (2008) 1.05
Germline genetic variations in drug action pathways predict clinical outcomes in advanced lung cancer treated with platinum-based chemotherapy. Pharmacogenet Genomics (2008) 1.05